The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections - PubMed (original) (raw)
The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections
M A Calder et al. Drugs. 1986.
Abstract
The incidence of Branhamella catarrhalis in respiratory infections at City Hospital, Edinburgh from January 1981 to April 1984 is described. Beginning in January 1982 there was an increased incidence associated with a high proportion of beta-lactamase-producing strains. The number of these strains increased: from January 1981 to April 1983, 61% of strains produced beta-lactamase, and 83% produced beta-lactamase from January to April 1984. 53% of patients were infected in hospital. Environmental studies showed that 7% of staff and 8% of patients were carriers; there was also circumstantial evidence of ward and patient-to-patient infection. The antimicrobial susceptibility of 54 clinical strains was tested: all strains were resistant to trimethoprim but were susceptible to clavulanic acid plus amoxycillin, chloramphenicol, erythromycin, co-trimoxazole, cefotaxime and cefuroxime. beta-Lactamase-negative strains were uniformly susceptible to penicillin and ampicillin.
Similar articles
- In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis.
Alvarez S, Jones M, Holtsclaw-Berk S, Guarderas J, Berk SL. Alvarez S, et al. Antimicrob Agents Chemother. 1985 Apr;27(4):646-7. doi: 10.1128/AAC.27.4.646. Antimicrob Agents Chemother. 1985. PMID: 3873905 Free PMC article. - Antibiotic susceptibility of beta-lactamase-producing strains of Branhamella (Neisseria) catarrhalis.
Doern GV, Siebers KG, Hallick LM, Morse SA. Doern GV, et al. Antimicrob Agents Chemother. 1980 Jan;17(1):24-9. doi: 10.1128/AAC.17.1.24. Antimicrob Agents Chemother. 1980. PMID: 6766292 Free PMC article. - Antimicrobial susceptibility of Branhamella catarrhalis isolates from bronchopulmonary infections.
Ahmad F, McLeod DT, Croughan MJ, Calder MA. Ahmad F, et al. Antimicrob Agents Chemother. 1984 Sep;26(3):424-5. doi: 10.1128/AAC.26.3.424. Antimicrob Agents Chemother. 1984. PMID: 6508272 Free PMC article. - Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
Enright MC, McKenzie H. Enright MC, et al. J Med Microbiol. 1997 May;46(5):360-71. doi: 10.1099/00222615-46-5-360. J Med Microbiol. 1997. PMID: 9152030 Review. - Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
Schito GC, Pesce A, Debbia EA. Schito GC, et al. Drugs. 1994;47 Suppl 3:1-8; discussion 8-9. doi: 10.2165/00003495-199400473-00003. Drugs. 1994. PMID: 7518761 Review.
Cited by
- Clinical features fail to distinguish respiratory infections caused by Branhamella catarrhalis from those caused by Haemophilus influenzae.
Forward KR. Forward KR. Can J Infect Dis. 1992 Jan;3(1):19-22. doi: 10.1155/1992/489597. Can J Infect Dis. 1992. PMID: 22451757 Free PMC article. - Pulmonary thin-section CT findings in acute Moraxella catarrhalis pulmonary infection.
Okada F, Ando Y, Nakayama T, Tanoue S, Ishii R, Ono A, Watanabe M, Takaki H, Maeda T, Mori H. Okada F, et al. Br J Radiol. 2011 Dec;84(1008):1109-14. doi: 10.1259/bjr/42762966. Epub 2010 Dec 1. Br J Radiol. 2011. PMID: 21123308 Free PMC article. - The other siblings: respiratory infections caused by Moraxella catarrhalis and Haemophilus influenzae.
Lutwick L, Fernandes L. Lutwick L, et al. Curr Infect Dis Rep. 2006 May;8(3):215-21. doi: 10.1007/s11908-006-0062-0. Curr Infect Dis Rep. 2006. PMID: 16643773 - Moraxella catarrhalis: from emerging to established pathogen.
Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A. Verduin CM, et al. Clin Microbiol Rev. 2002 Jan;15(1):125-44. doi: 10.1128/CMR.15.1.125-144.2002. Clin Microbiol Rev. 2002. PMID: 11781271 Free PMC article. Review. - Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
McGregor K, Chang BJ, Mee BJ, Riley TV. McGregor K, et al. Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):219-34. doi: 10.1007/BF01699978. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9707304 Review.
References
- Lancet. 1980 Jun 14;1(8181):1270-3 - PubMed
- Lancet. 1984 Apr 7;1(8380):782-3 - PubMed
- Lancet. 1977 Dec 3;2(8049):1175 - PubMed
- Br Med J. 1978 Feb 4;1(6108):276-8 - PubMed
- Br Med J (Clin Res Ed). 1983 Nov 12;287(6403):1446-7 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous